Over 380 clinicians and practitioners signed a letter, requesting the DEA to issue a revised proposed rule to regulate the prescribing of controlled substances through telehealth as soon as possible to ensure adequate time for patients to continue existing care.

To read a full copy of the stakeholder letter, please click here.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [116.12 KB]